stockrowIronwood Pharmaceuticals, Inc. (IRWD) vs Tilray Brands, Inc. (TLRY)
- Ironwood Pharmaceuticals, Inc. IRWD 3.94 +4.51%
- Tilray Brands, Inc. TLRY 2.81 −5.07%
Ironwood Pharmaceuticals, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $665.9M against $415.3M — 1.6× the size. Tilray Brands, Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 4.3×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 18.1% against 15.9%. Ironwood Pharmaceuticals, Inc. has the higher net margin (37.4% vs −17.1%) and the higher return on invested capital (0.00% vs −3.21%). Across the 18 metrics below, Ironwood Pharmaceuticals, Inc. leads on 13 and Tilray Brands, Inc. on 5.
Valuation
Profitability
| Metric | IRWD | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 29.12% | 53.51% |
| Operating margin | 62.91% | (9.26%) | 0.00% |
| Net margin | 37.38% | (17.05%) | (2.45%) |
| Free cash flow margin | 51.31% | (19.10%) | 0.00% |
| Return on equity | (82.81%) | (10.50%) | (0.80%) |
| Return on assets | 43.58% | (7.45%) | (1.67%) |
| Return on invested capital | 0.00% | (3.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack